Arra::yes::arra recovery act - tissue source site (TSS) networks in support of the cancer genome atlas (tcga) program

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201000056C
Awardee
Awarding agency
Obligated
$4,068,046

Award facts

Opportunity
Contract value 18% obligated
  • $4,068,045.88 Current, with exercised options
  • $23,009,371.88 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Detroit, MI 48202, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00022 -$154,924
Other Administrative Action 21 $0
Other Administrative Action 20 $0
Other Administrative Action 19 -$1,375,091
Other Administrative Action 18 $0
Other Administrative Action 17 $0
Other Administrative Action 16 $0
Exercise an Option 15 $237,083
Other Administrative Action 14 $0
Other Administrative Action 13 $0
Other Administrative Action 12 $0
Other Administrative Action 11 $0
Other Administrative Action 10 $0
Other Administrative Action 9 $0
Other Administrative Action 8 $0
Novation Agreement 7 $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 · Recovery act - tissue source site (TSS) in support of the cancer genome atlas (tcga) program $0
Other Administrative Action 1 $0
Original award $5,360,978
Show all 23

About this award

The National Cancer Institute awarded a definitive contract to Asterand, Inc. for Tissue Source Site (TSS) networks in support of the Cancer Genome Atlas (TCGA) program on September 24, 2010, with a ceiling value of $23.0 million.

The contract is funded under the American Recovery and Reinvestment Act and structured as cost-plus-fixed-fee. Place of performance is Detroit, MI. The ultimate completion date is September 30, 2019.

Quick answers

Who was awarded contract HHSN261201000056C?

HHSN261201000056C was awarded to Asterand, Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2010.

How much is contract HHSN261201000056C worth?

The government has obligated $4,068,046 on HHSN261201000056C. Its potential value, with all options, is $23,009,372.

Was contract HHSN261201000056C competed?

The extent of competition for HHSN261201000056C was full and open competition. The government received 9 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award